World Cancer Day 2024

February 4th is World Cancer Day to raise global cancer awareness. At LS CancerDiag, our purpose is to provide reliable and easy-to-access diagnostics for Lynch syndrome and promote awareness about hereditary cancer risks. Guided by

... read more

LSCD at the CGA-IGC Annual Meeting 2023

LS CancerDiag attends the CGA-IGC Annual Meeting as the main partner Following our earlier announcement on the partnership with CGA-IGC, we attended their Annual Meeting in Las Vegas to launch our closer collaboration. The Collaborative

... read more

Meet our Team: Anu Harju

Lab Technician Anu Harju enjoys the routine work at the lab – Biology ensures no two two days are identical Anu Harju has worked as a laboratory technician at LS CancerDiag for three and a

... read more

LSCD Industry Symposium

Welcome to the LS CancerDiag Industry Symposium at the 2023 CGA-IGC Annual Meeting! A couple of weeks ago, we announced our partnership with The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC). One

... read more

CGA-IGC Partnership Announcement

LS CancerDiag entered a new partnership with The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer As we honored the #HereditaryCancerWeek last week, we took the occasion to announce our partnership with CGA-IGC. The

... read more

Meet our Team: Tea Kuivala

More than theory: Learnings of a master’s student in life science startup Tea Kuivala started working for LS CancerDiag as a part-time employee alongside her studies in genetics and molecular biosciences at the University of

... read more

We have moved to new premises!

LS CancerDiag has new laboratory and office premises in Arabianranta, Helsinki During the Summer, LS CancerDiag moved to a new location in Helsinki. The new premises will serve as the global company headquarters and central

... read more

Meet our CSO, Dr. Minttu Kansikas

Minttu Kansikas, Ph.D., Chief Scientific Officer of LS CancerDiag, is one of the inventors of the method behind the DiagMMR test. She has been inspired by genetics since high school. She has enjoyed the field

... read more

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.